Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2017 /
Toxicities in treatments of lung cancers with respect to the elderly

9th - 11th Nov 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.11.17
Views: 1147

Dr Lore Decoster - UZ Brussel, Brussels, Belgium

Dr Decoster talks to ecancer at SIOG 2017 in Warsaw.

She discusses the situation surrounding older patients with small cell lung cancers using immunotherapy and targeted therapies.

There is a lack of data in patients aged 75, so further research is needed here. 

There is potential with targeted tyrosine kinase inhibitors, as they have fewer toxicities.

She finishes by weighing up the balance between toxicities and quality of life.

This service has been kindly supported by an unrestricted grant from Janssen Oncology.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation